Helicobacter pylori infection: Host immune response, implications on gene expression and MicroRNAs

World Journal of Gastroenterology

Volumn 20, Issue 6, 2014, Pages 1424-1437

  Cadamuro, Aline Cristina Targa ^a   Rossi, Ana Flávia Teixeira ^a   Maniezzo, Nathália Maciel ^a   Silva, Ana Elizabete ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Gastric cancer; Gastric lesions; Gene expression; Helicobacter pylori; Immune response; Inflammation; MicroRNAs; Virulence factors

Indexed keywords

CAGA PROTEIN; CXCL1 CHEMOKINE; CXCL14 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MICRORNA; MICRORNA 103; MICRORNA 146A; MICRORNA 155; MICRORNA 17; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 222; MICRORNA 223; MICRORNA 25; MICRORNA 370; MICRORNA 372; MICRORNA 373; MICRORNA 375; MICRORNA 449; MICRORNA 584; MICRORNA 93; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PATHOGEN CLEARANCE; PRECANCER; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH EPITHELIUM; TH1 CELL; TH17 CELL; UPREGULATION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; RISK FACTOR; STOMACH MUCOSA; STOMACH TUMOR;

APOPTOSIS; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MICRORNAS; RISK FACTORS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VIRULENCE FACTORS;

EID: 84893772321     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i6.1424     Document Type: Article

References (144)

1. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29: 559-578 [PMID: 11030073 DOI: 10.1016/ S0889-8553(05)70130-8]
2. Ricci V, Romano M, Boquet P. Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol 2011; 17: 1383-1399 [PMID: 21472096 DOI: 10.3748/wjg.v17.i11.1383]
3. Zarrilli R, Ricci V, Romano M. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell Microbiol 1999; 1: 93-99 [PMID: 11207544 DOI: 10.1046/j.1462-5822.1999.00018.x]
4. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999; 13 Suppl 1: 3-11 [PMID: 10209681 DOI: 10.1046/ j.1365-2036.1999.00002.x]
5. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186 [PMID: 12374879 DOI: 10.1056/NEJMra020542]
6. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-615 [PMID: 22575588 DOI: 10.1016/ S1470-2045(12)70137-7]
7. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
8. Van Doorn LJ, Figueiredo C, Mégraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R, De Boer W, Schneeberger PM, Correa P, Ng EK, Atherton J, Blaser MJ, Quint WG. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999; 116: 823-830 [PMID: 10092304 DOI: 10.1016/S0016-5085(99)70065-X]
9. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412: 99 [PMID: 11808612 DOI: 10.1038/35083631]
10. Sachs G, Scott DR. Helicobacter pylori: Eradication or Preservation. F1000 Med Rep 2012; 4: 7 [PMID: 22500191 DOI: 10.3410/M4-7]
11. Li ZW, Wu Y, Sun Y, Liu LY, Tian MM, Feng GS, You WC, Li JY. Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia. World J Gastroenterol 2010; 16: 1788-1794 [PMID: 20380014 DOI: 10.3748/wjg.v16.i14.1788]
12. Crusius JB, Canzian F, Capellá G, Peña AS, Pera G, Sala N, Agudo A, Rico F, Del Giudice G, Palli D, Plebani M, Boeing H, Bueno-de-Mesquita HB, Carneiro F, Pala V, Save VE, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martínez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Binghan S, Caldas C, Linseisen J, Kaaks R, Overvad K, Tjønneland A, Büchner FC, Peeters PH, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Rinaldi S, Ferrari P, Riboli E, González CA. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPICEURGAST). Ann Oncol 2008; 19: 1894-1902 [PMID: 18628242 DOI: 10.1093/annonc/mdn400]
13. Oliveira JG, Duarte MC, Silva AE. IL-1ra anti-inflammatory cytokine polymorphism is associated with risk of gastric cancer and chronic gastritis in a Brazilian population, but the TNF-β pro-inflammatory cytokine is not. Mol Biol Rep 2012; 39: 7617-7625 [PMID: 22327782 DOI: 10.1007/s11033-012-1596-x]
14. de Oliveira JG, Rossi AF, Nizato DM, Miyasaki K, Silva AE. Profiles of gene polymorphisms in cytokines and Toll-like receptors with higher risk for gastric cancer. Dig Dis Sci 2013; 58: 978-988 [PMID: 23086128 DOI: 10.1007/ s10620-012-2460-5]
15. de Oliveira JG, Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012; 18: 1235-1242 [PMID: 22468087 DOI: 10.3748/wjg.v18.i11.1235]
16. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20: 633-649 [PMID: 16997150 DOI: 10.1016/j.bpg.2006.04.008]
17. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009; 15: 971-976 [PMID: 19874380 DOI: 10.1111/j.1469-0691.2009.03031.x]
18. De Flora S, Bonanni P. The prevention of infection-associated cancers. Carcinogenesis 2011; 32: 787-795 [PMID: 21436188 DOI: 10.1093/carcin/bgr054]
19. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol 2009; 44: 239-248 [PMID: 19271114 DOI: 10.1007/s00535-009-0014-1]
20. Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12: 2979-2990 [PMID: 16718776 DOI: 10.3748/wjg.v12. i19.2979]
21. Kim KK, Kim HB. Protein interaction network related to Helicobacter pylori infection response. World J Gastroenterol 2009; 15: 4518-4528 [PMID: 19777610 DOI: 10.3748/ wjg.15.4518]
22. Backert S, Meyer TF. Type IV secretion systems and their effectors in bacterial pathogenesis. Curr Opin Microbiol 2006; 9: 207-217 [PMID: 16529981 DOI: 10.1016/j.mib.2006.02.008]
23. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134: 306-323 [PMID: 18166359 DOI: 10.1053/j.gastro.2007.11.009]
24. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009; 282: 1-8 [PMID: 19111390 DOI: 10.1016/j.canlet.2008.11.016]
25. Bauer B, Meyer TF. The human gastric pathogen Helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcer 2011; 2011: 1-23 [DOI: 10.1155/2011/340157]
26. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-14653 [PMID: 8962108 DOI: 10.1073/ pnas.93.25.14648]
27. Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, Naumann M, Meyer TF. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2000; 2: 155-164 [PMID: 11207572 DOI: 10.1046/ j.1462-5822.2000.00043.x]
28. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T, Hatakeyama M. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279: 17205-17216 [PMID: 14963045 DOI: 10.1074/ jbc.M309964200]
29. Backert S, Tegtmeyer N, Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 2010; 15: 163-176 [PMID: 20557357 DOI: 10.1111/j.1523-5378.2010.00759.x]
30. Li N, Han L, Chen J, Lin X, Chen H, She F. Proliferative and apoptotic effects of gastric epithelial cells induced by coccoid Helicobacter pylori. J Basic Microbiol 2013; 53: 147-155 [PMID: 22581720 DOI: 10.1002/jobm.201100370]
31. Maeda S, Yoshida H, Mitsuno Y, Hirata Y, Ogura K, Shiratori Y, Omata M. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Mol Pathol 2002; 55: 286-293 [PMID: 12354930 DOI: 10.1136/ gut.50.6.771]
32. Truong BX, Mai VT, Tanaka H, Ly le T, Thong TM, Hai HH, Van Long D, Furumatsu K, Yoshida M, Kutsumi H, Azuma T. Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer. J Clin Microbiol 2009; 47: 4021-4028 [PMID: 19846630 DOI: 10.1128/JCM.00504-09]
33. Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995; 73: 760-770 [PMID: 8558837]
34. Brandt S, Kwok T, Hartig R, König W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 2005; 102: 9300-9305 [PMID: 15972330 DOI: 10.1073/pnas.0409873102]
35. Yang JJ, Cho LY, Ma SH, Ko KP, Shin A, Choi BY, Han DS, Song KS, Kim YS, Chang SH, Shin HR, Kang D, Yoo KY, Park SK. Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study. PLoS One 2011; 6: e21155 [PMID: 21698158 DOI: 10.1371/journal.pone.0021155]
36. Karami N, Talebkhan Y, Saberi S, Esmaeili M, Oghalaie A, Abdirad A, Mostafavi E, Hosseini ME, Mohagheghi MA, Mohammadi M. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer. Asian Pac J Cancer Prev 2013; 14: 1813-1817 [PMID: 23679279]
37. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010; 7: 629-641 [PMID: 20938460 DOI: 10.1038/nrgastro.2010.154]
38. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133: 926-936 [PMID: 17854597 DOI: 10.1053/j.gastro.2007.06.056]
39. Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10: 403-414 [PMID: 20495574 DOI: 10.1038/nrc2857]
40. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, Rugge M, Plebani M, Atherton JC. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135: 91-99 [PMID: 18474244 DOI: 10.1053/ j.gastro.2008.03.041]
41. Peek RM. Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: implications for carcinogenesis. J Gastroenterol 2002; 37 Suppl 13: 10-16 [PMID: 12109657 DOI: 10.1007/BF02990093]
42. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med 2000; 191: 115-128 [PMID: 10620610 DOI: 10.1084/ jem.191.1.115]
43. Zheng PY, Jones NL. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol 2003; 5: 25-40 [PMID: 12542468 DOI: 10.1046/j.1462-5822.2003.00250.x]
44. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301: 1099-1102 [PMID: 12934009 DOI: 10.1126/science.1086871]
45. Mahdavi J, Sondén B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, Altraja S, Wadström T, Kersulyte D, Berg DE, Dubois A, Petersson C, Magnusson KE, Norberg T, Lindh F, Lundskog BB, Arnqvist A, Hammarström L, Borén T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002; 297: 573-578 [PMID: 12142529 DOI: 10.1126/science.1069076]
46. Prinz C, Schöniger M, Rad R, Becker I, Keiditsch E, Wagenpfeil S, Classen M, Rösch T, Schepp W, Gerhard M. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 2001; 61: 1903-1909 [PMID: 11280745]
47. Rad R, Gerhard M, Lang R, Schöniger M, Rösch T, Schepp W, Becker I, Wagner H, Prinz C. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 2002; 168: 3033-3041 [PMID: 11884476]
48. Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96: 12778-12783 [PMID: 10535999 DOI: 10.1128/IAI.00334-07]
49. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000; 97: 7533-7538 [PMID: 10852959 DOI: 10.1073ypnas.130079797]
50. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002; 123: 414-424 [PMID: 12145793 DOI: 10.1053/gast.2002.34781]
51. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128: 833-848 [PMID: 15825067 DOI: 10.1053/ j.gastro.2005.01.009]
52. Imagawa S, Ito M, Yoshihara M, Eguchi H, Tanaka S, Chayama K. Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer development. J Med Microbiol 2010; 59: 1484-1489 [PMID: 20829397 DOI: 10.1099/jmm.0.021816-0]
53. Nguyen LT, Uchida T, Tsukamoto Y, Kuroda A, Okimoto T, Kodama M, Murakami K, Fujioka T, Moriyama M. Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population. Clin Microbiol Infect 2010; 16: 1264-1269 [PMID: 19832706 DOI: 10.1111/ j.1469-0691.2009.03081.x]
54. Peek RM, Thompson SA, Donahue JP, Tham KT, Atherton JC, Blaser MJ, Miller GG. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians 1998; 110: 531-544 [PMID: 9824536]
55. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simões M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687 [PMID: 12441323 DOI: 10.1093/ jnci/94.22.1680]
56. Sgouros SN, Bergele C. Clinical outcome of patients with Helicobacter pylori infection: the bug, the host, or the environment? Postgrad Med J 2006; 82: 338-342 [PMID: 16679473 DOI: 10.1136/pgmj.2005.038273]
57. Ramis IB, Fonseca TL, de Moraes EP, Fernandes MS, Mendoza-Sassi R, Rodrigues O, Juliano CR, Scaini CJ, da Silva PE. Molecular Basis of pathogenicity in Helicobacter pylori clinical isolates. J Clin Microbiol 2010; 48: 3776-3778 [PMID: 20686086 DOI: 10.1128/JCM.00472-10]
58. Garcia GT, Aranda KR, Gonçalves ME, Cardoso SR, Iriya K, Silva NP, Scaletsky IC. High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol 2010; 48: 4266-4268 [PMID: 20826649 DOI: 10.1128/ JCM.01034-10]
59. Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, Tang H. MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life 2012; 64: 628-635 [PMID: 22539488 DOI: 10.1002/iub.1030]
60. Baud J, Varon C, Chabas S, Chambonnier L, Darfeuille F, Staedel C. Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. PLoS One 2013; 8: e60315 [PMID: 23565224 DOI: 10.1371/journal. pone.0060315]
61. Liu X, Ru J, Zhang J, Zhu LH, Liu M, Li X, Tang H. miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells. PLoS One 2013; 8: e64707 [PMID: 23785404 DOI: 10.1371/journal.pone.0064707]
62. Kang JY, Lee JO. Structural biology of the Toll-like receptor family. Annu Rev Biochem 2011; 80: 917-941 [PMID: 21548780 DOI: 10.1146/annurev-biochem-052909-141507]
63. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376 [PMID: 12524386]
64. Matsuura M. Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity. Front Immunol 2013; 4: 109 [PMID: 23745121 DOI: 10.3389/fimmu.2013.00109]
65. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Microbiol 2007; 51: 140-148 [PMID: 17645528]
66. Kumar Pachathundikandi S, Brandt S, Madassery J, Backert S. Induction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-α. PLoS One 2011; 6: e19614 [PMID: 21573018 DOI: 10.1371/journal.pone.0019614]
67. Bartchewsky W, Martini MR, Masiero M, Squassoni AC, Alvarez MC, Ladeira MS, Salvatore D, Trevisan M, Pedrazzoli J, Ribeiro ML. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Scand J Gastroenterol 2009; 44: 153-161 [PMID: 18985541 DOI: 10.1080/00365520802530853]
68. Isomoto H, Moss J, Hirayama T. Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. Tohoku J Exp Med 2010; 220: 3-14 [PMID: 20046046]
69. Argent RH, Thomas RJ, Letley DP, Rittig MG, Hardie KR, Atherton JC. Functional association between the Helicobacter pylori virulence factors VacA and CagA. J Med Microbiol 2008; 57: 145-150 [PMID: 18201978 DOI: 10.1099/ jmm.0.47465-0]
70. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296 [PMID: 15294155 DOI: 10.1016/ j.cell.2004.07.013]
71. Ding SZ, Goldberg JB, Hatakeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol 2010; 6: 851-862 [PMID: 20465395 DOI: 10.2217/fon.10.37]
72. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 2004; 101: 7727-7732 [PMID: 15128946]
73. Luo JJ, Li CY, Liu S, Yu W, Tang SY, Cai HL, Zhang Y. Overexpression of Helicobacter pylori VacA N-terminal fragment induces proinflammatory cytokine expression and apoptosis in human monocytic cell line through activation of NF-κB. Can J Microbiol 2013; 59: 523-533 [PMID: 23898995 DOI: 10.1139/cjm-2013]
74. Freedman DO. Imported malaria--here to stay. Am J Med 1992; 93: 239-242 [PMID: 1524073]
75. Telford JL, Covacci A, Rappuoli R, Chiara P. Immunobiology of Helicobacter pylori infection. Curr Opin Immunol 1997; 9: 498-503 [PMID: 9287174]
76. Alvarez-Arellano L, Camorlinga-Ponce M, Maldonado-Bernal C, Torres J. Activation of human neutrophils with Helicobacter pylori and the role of Toll-like receptors 2 and 4 in the response. FEMS Immunol Med Microbiol 2007; 51: 473-479 [PMID: 17892476]
77. Fehlings M, Drobbe L, Moos V, Renner Viveros P, Hagen J, Beigier-Bompadre M, Pang E, Belogolova E, Churin Y, Schneider T, Meyer TF, Aebischer T, Ignatius R. Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect Immun 2012; 80: 2724-2734 [PMID: 22615251 DOI: 10.1128/ IAI.00381-12]
78. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010; 10: 427-439 [PMID: 20498669 DOI: 10.1038/nri2779]
79. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007; 133: 288-308 [PMID: 17631150]
80. Rolig AS, Cech C, Ahler E, Carter JE, Ottemann KM. The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infect Immun 2013; 81: 1382-1389 [PMID: 23429529 DOI: 10.1128/ IAI.00044-13]
81. Weiss G, Forster S, Irving A, Tate M, Ferrero RL, Hertzog P, Frøkiær H, Kaparakis-Liaskos M. Helicobacter pylori VacA suppresses Lactobacillus acidophilus-induced interferon beta signaling in macrophages via alterations in the endocytic pathway. MBio 2013; 4: e00609-e00612 [PMID: 23760466 DOI: 10.1128/mBio.00609-12]
82. Lindholm C, Quiding-Järbrink M, Lönroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 5964-5971 [PMID: 9826379]
83. Galgani M, Busiello I, Censini S, Zappacosta S, Racioppi L, Zarrilli R. Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island. Infect Immun 2004; 72: 4480-4485 [PMID: 15271906]
84. Bornschein J, Kandulski A, Selgrad M, Malfertheiner P. From gastric inflammation to gastric cancer. Dig Dis 2010; 28: 609-614 [PMID: 21088411 DOI: 10.1159/000320061]
85. Au PY, Yeh WC. Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv Exp Med Biol 2007; 597: 32-47 [PMID: 17633015]
86. Chang YJ, Wu MS, Lin JT, Sheu BS, Muta T, Inoue H, Chen CC. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol Pharmacol 2004; 66: 1465-1477 [PMID: 15456896]
87. Sierra JC, Hobbs S, Chaturvedi R, Yan F, Wilson KT, Peek RM, Polk DB. Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2013; 305: G196-G203 [PMID: 23681474 DOI: 10.1152/ajpgi.00495.2012]
88. Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek RM. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis 2009; 199: 641-651 [PMID: 19199544 DOI: 10.1086/596660]
89. Tabassam FH, Graham DY, Yamaoka Y. Helicobacter pylori activate epidermal growth factor receptorand phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol 2009; 11: 70-82 [PMID: 18782353 DOI: 10.1111/j.1462-5822.2008.01237.x]
90. Kim DY, Cha ST, Ahn DH, Kang HY, Kwon CI, Ko KH, Hwang SG, Park PW, Rim KS, Hong SP. STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol 2009; 24: 646-651 [PMID: 19175826 DOI: 10.1111/ j.1440-1746.2008.05671.x]
91. Jang J, Lee S, Jung Y, Song K, Fukumoto M, Gould VE, Lee I. Malgun (clear) cell change in Helicobacter pylori gastritis reflects epithelial genomic damage and repair. Am J Pathol 2003; 162: 1203-1211 [PMID: 12651612 DOI: 10.1016/ S0002-9440(10)63916-8]
92. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-845 [PMID: 18645592 DOI: 10.1038/ni.f.209]
93. Hocèsde la Guardia A, Staedel C, Kaafarany I, Clément A, Roubaud Baudron C, Mégraud F, Lehours P. Inflammatory cytokine and microRNA responses of primary human dendritic cells cultured with Helicobacter pylori strains. Front Microbiol 2013; 4: 236 [PMID: 23970881 DOI: 10.3389/ fmicb.2013.00236]
94. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, Sun L, Ji G, Shi Y, Han Z, Han S, Nie Y, Chen X, Zhao Q, Ding J, Wu K, Daiming F. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011; 9: 824-833 [PMID: 21628394 DOI: 10.1158/1541-7786.MCR-10-0529]
95. Yokota S, Okabayashi T, Rehli M, Fujii N, Amano K. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect Immun 2010; 78: 468-476 [PMID: 19858308 DOI: 10.1128/IAI.00903-09]
96. Frey MR, Golovin A, Polk DB. Epidermal growth factorstimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J Biol Chem 2004; 279: 44513-44521 [PMID: 15316018 DOI: 10.1074/jbc. M406253200]
97. Hofman VJ, Moreilhon C, Brest PD, Lassalle S, Le Brigand K, Sicard D, Raymond J, Lamarque D, Hébuterne XA, Mari B, Barbry PJ, Hofman PM. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol 2007; 20: 974-989 [PMID: 17643099 DOI: 10.1038/modpathol.3800930]
98. Yang ZM, Chen WW, Wang YF. Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis. PLoS One 2012; 7: e33030 [PMID: 22438889]
99. Pimentel-Nunes P, Gonçalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter 2013; 18: 22-32 [PMID: 23061653 DOI: 10.1111/hel.12008]
100. Garza-González E, Bocanegra-García V, Bosques-Padilla FJ, Flores-Gutiérrez JP, Moreno F, Perez-Perez GI. mRNA levels of TLR4 and TLR5 are independent of H pylori. World J Gastroenterol 2008; 14: 5306-5310 [PMID: 18785283 DOI: 10.3748/wjg.14.5306]
101. Masumoto J, Yang K, Varambally S, Hasegawa M, Tomlins SA, Qiu S, Fujimoto Y, Kawasaki A, Foster SJ, Horie Y, Mak TW, Núñez G, Chinnaiyan AM, Fukase K, Inohara N. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 2006; 203: 203-213 [PMID: 16418393 DOI: 10.1084/jem.20051229]
102. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, Philpott DJ. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007; 26: 445-459 [PMID: 17433730 DOI: 10.1016/ j.immuni.2007.03.009]
103. Allison CC, Ferrand J, McLeod L, Hassan M, KaparakisLiaskos M, Grubman A, Bhathal PS, Dev A, Sievert W, Jenkins BJ, Ferrero RL. Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severity. J Immunol 2013; 190: 3706-3715 [PMID: 23460743 DOI: 10.4049/jimmunol.1200591]
104. Jackson CB, Judd LM, Menheniott TR, Kronborg I, Dow C, Yeomans ND, Boussioutas A, Robb L, Giraud AS. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 2007; 213: 140-151 [PMID: 17724739 DOI: 10.1002/path.2218]
105. Sohn SH, Lee YC. The genome-wide expression profile of gastric epithelial cells infected by naturally occurring cagA isogenic strains of Helicobacter pylori. Environ Toxicol Pharmacol 2011; 32: 382-389 [PMID: 22004957 DOI: 10.1016/ j.etap.2011.08.006]
106. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, van der Merwe S, Vaz Coelho LG, Fock M, Fedail S, Cohen H, Malfertheiner P, Vakil N, Hamid S, Goh KL, Wong BC, Krabshuis J, Le Mair A. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis 2011; 20: 299-304 [PMID: 21961099 DOI: 10.1097/MCG.0b013e31820fb8f6]
107. Tsai CJ, Herrera-Goepfert R, Tibshirani RJ, Yang S, Mohar A, Guarner J, Parsonnet J. Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. Cancer Epidemiol Biomarkers Prev 2006; 15: 272-280 [PMID: 16492915 DOI: 10.1158/1055-9965.EPI-05-0632]
108. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 2011; 8: 79-88 [PMID: 21293508 DOI: 10.1038/nrgastro.2010.210]
109. Yoon JH, Baik GH, Sohn KM, Kim DY, Kim YS, Suk KT, Kim JB, Kim DJ, Kim JB, Shin WG, Kim HY, Baik IH, Jang HJ. Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol 2012; 18: 6628-6634 [PMID: 23236238 DOI: 10.3748/wjg.v18.i45.6628]
110. Kim SY, Lee SW, Hyun JJ, Jung SW, Koo JS, Yim HJ, Park JJ, Chun HJ, Choi JH. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy. J Clin Gastroenterol 2013; 47: 21-24 [PMID: 22647826 DOI: 10.1097/ MCG.0b013e3182548ad4]
111. Kindlund B, Sjöling A, Hansson M, Edebo A, Hansson LE, Sjövall H, Svennerholm AM, Lundin BS. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients. Helicobacter 2009; 14: 192-201 [PMID: 19702849 DOI: 10.1111/j.1523-5378.2009.00673.x]
112. Bauer B, Wex T, Kuester D, Meyer T, Malfertheiner P. Differential expression of human beta defensin 2 and 3 in gastric mucosa of Helicobacter pylori-infected individuals. Helicobacter 2013; 18: 6-12 [PMID: 23067102 DOI: 10.1111/ hel.12000]
113. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, Matzke M, Ruvkun G, Tuschl T. A uniform system for microRNA annotation. RNA 2003; 9: 277-279 [PMID: 12592000 DOI: 10.1261/rna.2183803]
114. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21and 22-nucleotide RNAs. Genes Dev 2001; 15: 188-200 [PMID: 11157775 DOI: 10.1101/gad.862301]
115. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001; 20: 6877-6888 [PMID: 11726523 DOI: 10.1093/ emboj/20.23.6877]
116. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63 [PMID: 18668040 DOI: 10.1038/nature07228]
117. Beilharz TH, Humphreys DT, Clancy JL, Thermann R, Martin DI, Hentze MW, Preiss T. microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS One 2009; 4: e6783 [PMID: 19710908 DOI: 10.1371/journal.pone.0006783]
118. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854 [PMID: 8252621 DOI: 10.1016/0092-8674(93)90529-Y]
119. Zhou P, Xu W, Peng X, Luo Z, Xing Q, Chen X, Hou C, Liang W, Zhou J, Wu X, Songyang Z, Jiang S. Large-scale screens of miRNA-mRNA interactions unveiled that the 3' UTR of a gene is targeted by multiple miRNAs. PLoS One 2013; 8: e68204 [PMID: 23874542 DOI: 10.1371/journal. pone.0068204]
120. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838 [PMID: 15944708 DOI: 10.1038/nature03702]
121. Oertli M, Engler DB, Kohler E, Koch M, Meyer TF, Müller A. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immunol 2011; 187: 3578-3586 [PMID: 21880981 DOI: 10.4049/jimmunol.1101772]
122. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003; 113: 25-36 [PMID: 12679032 DOI: 10.1016/S0092-8674(03)00231-9]
123. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88: 1358-1366 [PMID: 18794849 DOI: 10.1038/labinvest.2008.94]
124. Kawasaki H, Taira K. Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells. Nature 2003; 423: 838-842 [PMID: 12808467 DOI: 10.1038/nature01730]
125. Wang YS, Li SH, Guo J, Mihic A, Wu J, Sun L, Davis K, Weisel RD, Li RK. Role of miR-145 in cardiac myofibroblast differentiation. J Mol Cell Cardiol 2014; 66: 94-105 [PMID: 24001939 DOI: 10.1016/j.yjmcc.2013.08.007]
126. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-436 [PMID: 18230780 DOI: 10.1001/jama.299.4]
127. Ribeiro-dos-Santos Â, Khayat AS, Silva A, Alencar DO, Lobato J, Luz L, Pinheiro DG, Varuzza L, Assumpção M, Assumpção P, Santos S, Zanette DL, Silva WA, Burbano R, Darnet S. Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach. PLoS One 2010; 5: e13205 [PMID: 20949028 DOI: 10.1371/journal. pone.0013205]
128. Isomoto H, Matsushima K, Inoue N, Hayashi T, Nakayama T, Kunizaki M, Hidaka S, Nakayama M, Hisatsune J, Nakashima M, Nagayasu T, Nakao K, Hirayama T. Interweaving microRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection. J Clin Immunol 2012; 32: 290-299 [PMID: 22161133 DOI: 10.1007/ s10875-011-9626-3]
129. Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Tolllike receptor 4. PLoS One 2013; 8: e56709 [PMID: 23437218 DOI: 10.1371/journal.pone.0056709]
130. Shiotani A, Uedo N, Iishi H, Murao T, Kanzaki T, Kimura Y, Kamada T, Kusunoki H, Inoue K, Haruma K. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. J Gastroenterol 2012; 47: 988-998 [PMID: 22382634 DOI: 10.1007/ s00535-012-0562-7]
131. Liu Z, Xiao B, Tang B, Li B, Li N, Zhu E, Guo G, Gu J, Zhuang Y, Liu X, Ding H, Zhao X, Guo H, Mao X, Zou Q. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect 2010; 12: 854-863 [PMID: 20542134 DOI: 10.1016/j.micinf.2010.06.002]
132. Liu Z, Wang D, Hu Y, Zhou G, Zhu C, Yu Q, Chi Y, Cao Y, Jia C, Zou Q. MicroRNA-146a negatively regulates PTGS2 expression induced by Helicobacter pylori in human gastric epithelial cells. J Gastroenterol 2013; 48: 86-92 [PMID: 22699322 DOI: 10.1007/s00535-012-0609-9]
133. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009; 200: 916-925 [PMID: 19650740 DOI: 10.1086/605443]
134. Li N, Tang B, Zhu ED, Li BS, Zhuang Y, Yu S, Lu DS, Zou QM, Xiao B, Mao XH. Increased miR-222 in H. pyloriassociated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett 2012; 586: 722-728 [PMID: 22321642 DOI: 10.1016/ j.febslet.2012.01.025]
135. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011; 128: 361-370 [PMID: 20333682 DOI: 10.1002/ijc.25348]
136. Chen Q, Wang H, Liu Y, Song Y, Lai L, Han Q, Cao X, Wang Q. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3. PLoS One 2012; 7: e42971 [PMID: 22937006 DOI: 10.1371/journal.pone.0042971]
137. Feng Y, Wang L, Zeng J, Shen L, Liang X, Yu H, Liu S, Liu Z, Sun Y, Li W, Chen C, Jia J. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res 2013; 11: 834-844 [PMID: 23576572 DOI: 10.1158/1541-7786. MCR-13-0007]
138. Belair C, Baud J, Chabas S, Sharma CM, Vogel J, Staedel C, Darfeuille F. Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression. Silence 2011; 2: 7 [PMID: 22027184 DOI: 10.1186/1758-907X-2-7]
139. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B, Lund AH, Friis-Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29 [PMID: 21418558 DOI: 10.1186/1476-4598-10-29]
140. Zhu Y, Jiang Q, Lou X, Ji X, Wen Z, Wu J, Tao H, Jiang T, He W, Wang C, Du Q, Zheng S, Mao J, Huang J. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells. PLoS One 2012; 7: e35147 [PMID: 22536353 DOI: 10.1371/journal. pone.0035147]
141. Sayi A, Kohler E, Hitzler I, Arnold I, Schwendener R, Rehrauer H, Müller A. The CD4+ T cell-mediated IFNgamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J Immunol 2009; 182: 7085-7101 [PMID: 19454706 DOI: 10.4049/jimmunol.0803293]
142. Olivieri F, Spazzafumo L, Santini G, Lazzarini R, Albertini MC, Rippo MR, Galeazzi R, Abbatecola AM, Marcheselli F, Monti D, Ostan R, Cevenini E, Antonicelli R, Franceschi C, Procopio AD. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 2012; 133: 675-685 [PMID: 23041385 DOI: 10.1016/j.mad.2012.09.004]
143. Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW. Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma. Oncogene 2012; 31: 226-237 [PMID: 21666718 DOI: 10.1038/onc.2011.226]
144. Xu Z, Xiao SB, Xu P, Xie Q, Cao L, Wang D, Luo R, Zhong Y, Chen HC, Fang LR. miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J Biol Chem 2011; 286: 21401-21412 [PMID: 21518763 DOI: 10.1074/jbc.M110.198630]